Medtronic (NYSE: MDT) announced that the FDA approved expanded labeling for its deep brain stimulation (DBS) offering.

Edwards Lifesciences (NYSE: EW) today announced its plans to enter 2026 with momentum for sustainable, differentiated growth.

Boston Scientific (NYSE: BSX) announced recently that it received CE mark for its Farapoint pulsed field ablation (PFA) ...

GE HealthCare (Nasdaq: GEHC) announced today that it entered into a new collaboration with Mayo Clinic centered around cancer ...

Stryker (NYSE: SYK) announced today that it promoted Spencer Stiles to the position of president and chief operating officer ...

Atraverse Medical announced today that it received FDA clearance for its fully integrated Hotwire transseptal access system.

Johnson & Johnson MedTech (NYSE:JNJ) is enacting an organizational restructuring, changing the way its business units operate ...

Shoulder Innovations today announced a strategic partnership with Interventional Systems on a shoulder-specific micro-robotic ...

Medtronic (NYSE: MDT) announced that it appointed Dr. Gerald "Jeb" Denny as chief medical officer for Acute Care & Monitoring ...

Kestra Medical Technologies (Nasdaq:KMTS) announced that it priced an upsized underwritten offering worth approximately $138 ...

Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.

The report centers around Ireland’s position within the medtech industry as Europe’s second-largest exporter of medtech ...